acquisition is the sole category represented across all 1 tracked stories. Aspire Biopharma Holdings, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Kraig Higginson appears in 1 tracked Biotech story from August 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kraig Higginson
acquisition is the sole category represented across all 1 tracked stories. Aspire Biopharma Holdings, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Kraig Higginson appears in 1 tracked Biotech story from August 11, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kraig Higginson. Shared-story counts are live from our verified record — not editorial picks.
Aspire Biopharma, a Nasdaq-listed biotech, has closed the acquisition of Dura Driver Control Systems, a non-pharma automotive supplier. The $30 million all-cash deal brings over $200 million in annual revenue and $22.3 million in EBITDA, signaling a dramatic diversification away from pure drug development and into industrial cash flow generation.